BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 30722718)

  • 1. One-Year Results of the LIBERTY 360 Study: Evaluation of Acute and Midterm Clinical Outcomes of Peripheral Endovascular Device Interventions.
    Mustapha J; Gray W; Martinsen BJ; Bolduan RW; Adams GL; Ansel G; Jaff MR
    J Endovasc Ther; 2019 Apr; 26(2):143-154. PubMed ID: 30722718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. One-Year Outcomes of Peripheral Endovascular Device Intervention in Critical Limb Ischemia Patients: Sub-Analysis of the LIBERTY 360 Study.
    Mustapha JA; Igyarto Z; O'Connor D; Armstrong EJ; Iorio AR; Driver VR; Saab F; Behrens AN; Martinsen BJ; Adams GL
    Vasc Health Risk Manag; 2020; 16():57-66. PubMed ID: 32103970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three-Year Outcomes From the LIBERTY 360 Study of Endovascular Interventions for Peripheral Artery Disease Stratified by Rutherford Category.
    Giannopoulos S; Mustapha J; Gray WA; Ansel G; Adams G; Secemsky EA; Armstrong EJ
    J Endovasc Ther; 2021 Apr; 28(2):262-274. PubMed ID: 33016805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three-Year Outcomes of Orbital Atherectomy for the Endovascular Treatment of Infrainguinal Claudication or Chronic Limb-Threatening Ischemia.
    Giannopoulos S; Secemsky EA; Mustapha JA; Adams G; Beasley RE; Pliagas G; Armstrong EJ
    J Endovasc Ther; 2020 Oct; 27(5):714-725. PubMed ID: 32618486
    [No Abstract]   [Full Text] [Related]  

  • 5. Outcomes After Drug-Coated Balloon Treatment of Femoropopliteal Lesions in Patients With Critical Limb Ischemia: A Post Hoc Analysis From the IN.PACT Global Study.
    Reijnen MMPJ; van Wijck I; Zeller T; Micari A; Veroux P; Keirse K; Lee SW; Li P; Voulgaraki D; Holewijn S
    J Endovasc Ther; 2019 Jun; 26(3):305-315. PubMed ID: 30931726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary Self-EXPANDing Nitinol Stenting vs Balloon Angioplasty With Optional Bailout Stenting for the Treatment of Infrapopliteal Artery Disease in Patients With Severe Intermittent Claudication or Critical Limb Ischemia (EXPAND Study).
    Schulte KL; Pilger E; Schellong S; Tan KT; Baumann F; Langhoff R; Torsello G; Zeller T; Amendt K; Brodmann M;
    J Endovasc Ther; 2015 Oct; 22(5):690-7. PubMed ID: 26245919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Registry Assessment of Peripheral Interventional Devices objective performance goals for superficial femoral and popliteal artery peripheral vascular interventions.
    Bertges DJ; White R; Cheng YC; Sun T; Ramkumar N; Goodney PP; Wilgus RW; Lottes AE; Smale JA; Drozda J; Raska M; Heise T; Jones WS; Tcheng JE; Eldrup-Jorgensen J; Sedrakyan A; Malone ML; Marinac-Dabic D; Thatcher R; Morales P; Krucoff MW; Cronenwett JL;
    J Vasc Surg; 2021 May; 73(5):1702-1714.e11. PubMed ID: 33080324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Major Limb Outcomes Following Lower Extremity Endovascular Revascularization in Patients With and Without Diabetes Mellitus.
    Shammas AN; Jeon-Slaughter H; Tsai S; Khalili H; Ali M; Xu H; Rodriguez G; Cawich I; Armstrong EJ; Brilakis ES; Banerjee S
    J Endovasc Ther; 2017 Jun; 24(3):376-382. PubMed ID: 28440113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endovascular Revascularization Incorporating Infrapopliteal Coronary Drug-Eluting Stents Improves Clinical Outcomes in Patients with Critical Limb Ischemia and Tissue Loss.
    Huntress LA; Fereydooni A; Dardik A; Nassiri N
    Ann Vasc Surg; 2020 Feb; 63():234-240. PubMed ID: 31563654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of drug-eluting stents in patients with critical limb ischemia and infrapopliteal arterial disease: a real-world single-center experience.
    AbuRahma AF; Beasley M; Davis M; Adams E; Lee A; Shapiro J; Dean LS; Davis E
    J Vasc Surg; 2021 Nov; 74(5):1619-1625. PubMed ID: 34182023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endovascular-First Treatment Is Associated With Improved Amputation-Free Survival in Patients With Critical Limb Ischemia.
    Lin JH; Brunson A; Romano PS; Mell MW; Humphries MD
    Circ Cardiovasc Qual Outcomes; 2019 Aug; 12(8):e005273. PubMed ID: 31357888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes After Endovascular Revascularization in Octogenarians and Non-Octogenarians With Critical Limb Ischemia.
    Uhl C; Steinbauer M; Torsello G; Bisdas T;
    J Endovasc Ther; 2017 Aug; 24(4):471-477. PubMed ID: 28578624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy of an endovascular-first approach to acute limb ischemia.
    Poursina O; Elizondo-Adamchik H; Montero-Baker M; Pallister ZS; Mills JL; Chung J
    J Vasc Surg; 2021 May; 73(5):1741-1749. PubMed ID: 33068768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of endovascular therapy for femoropopliteal disease with the Supera stent.
    Montero-Baker M; Ziomek GJ; Leon L; Gonzales A; Dieter RS; Gadd CL; Pacanowski JP
    J Vasc Surg; 2016 Oct; 64(4):1002-8. PubMed ID: 27444365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of infrapopliteal post-PTA dissection with tack implants: 12-month results from the TOBA-BTK study.
    Brodmann M; Wissgott C; Holden A; Staffa R; Zeller T; Vasudevan T; Schneider P
    Catheter Cardiovasc Interv; 2018 Jul; 92(1):96-105. PubMed ID: 29573541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lower extremity revascularization using directional atherectomy: 12-month prospective results of the DEFINITIVE LE study.
    McKinsey JF; Zeller T; Rocha-Singh KJ; Jaff MR; Garcia LA;
    JACC Cardiovasc Interv; 2014 Aug; 7(8):923-33. PubMed ID: 25147039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endovascular Therapy Versus Bypass Surgery as First-Line Treatment Strategies for Critical Limb Ischemia: Results of the Interim Analysis of the CRITISCH Registry.
    Bisdas T; Borowski M; Stavroulakis K; Torsello G;
    JACC Cardiovasc Interv; 2016 Dec; 9(24):2557-2565. PubMed ID: 28007205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regional variation in outcomes for lower extremity vascular disease in the Vascular Quality Initiative.
    Soden PA; Zettervall SL; Shean KE; Vouyouka AG; Goodney PP; Mills JL; Hallett JW; Schermerhorn ML;
    J Vasc Surg; 2017 Sep; 66(3):810-818. PubMed ID: 28450103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Costs of Real-Life Endovascular Treatment of Critical Limb Ischemia: Report from Poland-A European Union Country with a Low-Budget Health Care System.
    Krzanowski M; Drelicharz L; Belowski A; Partyka L; Sumek-Brandys B; Ramakrishnan PK; Nizankowski R
    Ann Vasc Surg; 2016 Feb; 31():111-23. PubMed ID: 26616505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 3-Year Outcomes of the OLIVE Registry, a Prospective Multicenter Study of Patients With Critical Limb Ischemia: A Prospective, Multi-Center, Three-Year Follow-Up Study on Endovascular Treatment for Infra-Inguinal Vessel in Patients With Critical Limb Ischemia.
    Iida O; Nakamura M; Yamauchi Y; Fukunaga M; Yokoi Y; Yokoi H; Soga Y; Zen K; Suematsu N; Inoue N; Suzuki K; Hirano K; Shintani Y; Miyashita Y; Urasawa K; Kitano I; Tsuchiya T; Kawamoto K; Yamaoka T; Uesugi M; Shinke T; Oba Y; Ohura N; Uematsu M; Takahara M; Hamasaki T; Nanto S;
    JACC Cardiovasc Interv; 2015 Sep; 8(11):1493-1502. PubMed ID: 26404203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.